Our Recommendations
Filter
25
Featured
New Publications
11
Language
Document type
No document type
14
Guidelines
6
Studies & Reports
4
Strategic & Response Plan
1
Countries / Regions
Western and Central Europe
2
Africa
1
South Africa
1
Authors & Publishers
Publication Years
Category
HIV & STI
6
Policies & Guidelines HIV & TB
1
Toolboxes
ART Drug Resistance
25
Clinical Aspects, Treatment & Prevention
4
Drug resistance
4
Antiretroviral Treatment ART
3
Clinical Aspects
2
Treatment Guidelines HIV
2
Co-Morbidities (except TB)
2
HIV and coinfection
2
HIV testing & services
1
Treatment & Prevention
1
Laboratory
1
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
1
HIV in Key Populations
1
This concept note describes the methods used to assess the prevalence of any HIVDR and HIVDR by PMTCT exposure among children less than 18 months of age using remnant dried blood spot specimens from early infant diagnosis over a 12-month period
Technical Report
The goal of this Global Action Plan is to articulate synergistic actions that will be required to prevent HIVDR from undermining efforts to achieve global targets on health and HIV, and to provide the most effective treatment to all people living with HIV including adults, key populations, pregnant ...
Version 9.0
Octobre 2017
Co-trimoxazole is a fixed-dose combination of two antimicrobial drugs (sulfamethoxazole and trimethoprim) that covers a variety of bacterial, fungal and protozoan infections. Co-trimoxazole preventive therapy is a feasible, well tolerated and inexpensive intervention for people living with HIV to re...
